Target intelligence / Profile preview

Nucleoporin 35 pseudogene 2 (NUP35P2)

Target: NUP35P2
Molecular classification: Other (Pseudogene; not a member of major druggable gene families)

Overview

Nucleoporin 35 pseudogene 2 (NUP35P2) is a pseudogene corresponding to Nucleoporin 35, a component of the nuclear pore complex. Unlike NUP35, NUP35P2 does not encode a functional protein and has no established molecular function, biological role, or disease association[5]. It is not considered a therapeutic target, and its gene status reflects non-functionality rather than a true molecular entity involved in cellular processes.

Beyond the preview

Go deeper on Nucleoporin 35 pseudogene 2 (NUP35P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoporin 35 pseudogene 2 (NUP35P2).

Explore the full profile